EMA says clinical studies of AstraZeneca shows no blood clot
European Medicines Agency firmly convinced that benefits of AstraZeneca vaccine outweigh the risks, seeking to quell rising fears in Europe.
All News Here
European Medicines Agency firmly convinced that benefits of AstraZeneca vaccine outweigh the risks, seeking to quell rising fears in Europe.